Rachel Katz, MD, BS
Assistant Professor of PsychiatryCards
About
Research
Publications
2019
The Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary Lesion
Kitay BM, Katz RB, Wilkinson ST, Ostroff RB. The Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary Lesion. Journal Of Ect 2019, 35: e4-e5. PMID: 29952859, PMCID: PMC6309946, DOI: 10.1097/yct.0000000000000516.Peer-Reviewed Original Research
2018
The Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary Lesion
Kitay B, Katz R, Wilkinson S, Ostroff R. The Successful Use of Electroconvulsive Therapy in a Patient With Cerebral Aneurysms and a Pituitary Lesion. Journal Of Ect 2018, 1. DOI: 10.1097/00124509-900000000-99225.Peer-Reviewed Original ResearchErratum to: Ketamine: A Promising Rapid-Acting Antidepressant
Wilkinson S, Ostroff R, Katz R, Krystal J. Erratum to: Ketamine: A Promising Rapid-Acting Antidepressant. 2018, e1-e1. DOI: 10.1007/978-981-10-6577-4_24.Commentaries, Editorials and LettersS106. Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital
Wilkinson S, Webler R, Katz R, Toprak M, Ostroff R, Sanacora G. S106. Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital. Biological Psychiatry 2018, 83: s388. DOI: 10.1016/j.biopsych.2018.02.997.Peer-Reviewed Original ResearchThe Use of Electroconvulsive Therapy in Late-Life Psychiatric Disorders
Ostroff R, Katz R. The Use of Electroconvulsive Therapy in Late-Life Psychiatric Disorders. Current Treatment Options In Psychiatry 2018, 5: 228-241. DOI: 10.1007/s40501-018-0144-2.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsUse of ECTElectroconvulsive therapyTreatment of depressionMovement disordersDepressed Elderly (PRIDE) studySevere psychiatric illnessLife-saving treatmentWarrants further investigationProlonging RemissionPharmacologic treatmentGeriatric patientsElderly StudyClinical algorithmDementia syndromesPsychiatric illnessEffective treatmentParkinson's diseaseElderly populationPsychiatric disordersAge groupsTherapyRemissionTreatmentBehavioral dysregulationDisorders
2017
Integrating Behavioral Health and Primary Care
Katz R, Cherry B. Integrating Behavioral Health and Primary Care. American Journal Of Psychiatry 2017, 174: 1125-1125. DOI: 10.1176/appi.ajp.2017.17080927.Peer-Reviewed Original ResearchKetamine: A Promising Rapid-Acting Antidepressant
Wilkinson S, Ostroff R, Katz R, Krystal J. Ketamine: A Promising Rapid-Acting Antidepressant. 2017, 223-239. DOI: 10.1007/978-981-10-6577-4_16.Peer-Reviewed Original ResearchMood disordersDeficiency hypothesisInitiation of therapyRapid antidepressant effectsRapid acting antidepressantsEvidence-based treatmentsLong-term riskMood disorders researchRelapse prevention strategiesEfficient therapeutic targetMechanism of actionOral antidepressantsAntidepressant effectsGlutamatergic receptorsGlutamatergic systemNovel antidepressantsSingle doseClinical trialsKetamine exposureRelated symptomsLong-term effectsPsychiatric disordersPrevention strategiesTherapeutic targetDrug AdministrationA Case of Anesthesia Mumps with Electroconvulsive Therapy
Katz RB, Helgeson L, Ostroff R. A Case of Anesthesia Mumps with Electroconvulsive Therapy. Journal Of Ect 2017, 33: e6. PMID: 27922460, DOI: 10.1097/yct.0000000000000370.Peer-Reviewed Original ResearchProcedural Consolidation During Electroconvulsive Therapy for a Patient With Severe Tourette Syndrome.
Katz R, Bukanova E, Ostroff R. Procedural Consolidation During Electroconvulsive Therapy for a Patient With Severe Tourette Syndrome. The Journal Of ECT 2017, 33: e7-e8. PMID: 28009622, DOI: 10.1097/YCT.0000000000000378.Peer-Reviewed Original ResearchA Case Suspended in Time
Packer CD, Katz RB, Iacopetti CL, Krimmel JD, Singh MK. A Case Suspended in Time. Academic Medicine 2017, 92: 152-156. PMID: 27097050, DOI: 10.1097/acm.0000000000001199.Peer-Reviewed Original Research
Clinical Care
Overview
Rachel Katz, MD, is a psychiatrist who specializes in interventional psychiatry and mood disorders.
Dr. Katz focuses on diagnosing and treating various mental health conditions, including depression and anxiety, using advanced techniques to improve patient outcomes. She employs a range of approaches to manage these conditions, such as transcranial magnetic stimulation (TMS) and other therapeutic interventions.
An assistant professor of psychiatry at Yale School of Medicine, Dr. Katz received her medical training from Case Western Reserve University School of Medicine.
Clinical Specialties
Psychiatry
Yale Medicine News
News
News
- February 10, 2025
New Device at Yale Interventional Psychiatry Service Shortens TMS Delivery Time for Most Patients
- January 15, 2025
Yale-Led Study Will Compare Effectiveness of IV Ketamine and Esketamine Nasal Spray
- May 21, 2020Source: Yale Medicine
Stress, Anxiety, or Depression? Treatment Starts With the Right Diagnosis
- July 31, 2018Source: Biological Psychiatry
Acute and longer-term outcomes using ketamine as a clinical treatment at the Yale Psychiatric Hospital
Get In Touch
Contacts
Academic Office Number